Protyon
Groningen
About Protyon
Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $654.7K
- Funding stage: Seed
- Last round: Pre-Seed (May 2023)
- Website: protyon.tech
Industries & Categories
Clinical Trials, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/protyon-78117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.